List of Tables
Table 1. Global Late-Stage Oncology Drug Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Late-Stage Oncology Drug Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Late-Stage Oncology Drug Market Competitive Situation by Manufacturers in 2025
Table 4. Global Late-Stage Oncology Drug Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Late-Stage Oncology Drug Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Late-Stage Oncology Drug Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Late-Stage Oncology Drug Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Late-Stage Oncology Drug Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Late-Stage Oncology Drug, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Late-Stage Oncology Drug, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Late-Stage Oncology Drug, Product Types and Applications
Table 12. Global Key Manufacturers of Late-Stage Oncology Drug, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Late-Stage Oncology Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Late-Stage Oncology Drug Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Late-Stage Oncology Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Late-Stage Oncology Drug Sales by Region (kg), 2021–2026
Table 18. Global Late-Stage Oncology Drug Sales Market Share by Region (2021–2026)
Table 19. Global Late-Stage Oncology Drug Sales by Region (kg), 2027–2032
Table 20. Global Late-Stage Oncology Drug Sales Market Share by Region (2027–2032)
Table 21. Global Late-Stage Oncology Drug Revenue by Region (US$ Million), 2021–2026
Table 22. Global Late-Stage Oncology Drug Revenue Market Share by Region (2021–2026)
Table 23. Global Late-Stage Oncology Drug Revenue by Region (US$ Million), 2027–2032
Table 24. Global Late-Stage Oncology Drug Revenue Market Share by Region (2027–2032)
Table 25. North America Late-Stage Oncology Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Late-Stage Oncology Drug Sales by Country (kg), 2021–2026
Table 27. North America Late-Stage Oncology Drug Sales by Country (kg), 2027–2032
Table 28. North America Late-Stage Oncology Drug Revenue by Country (US$ Million), 2021–2026
Table 29. North America Late-Stage Oncology Drug Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Late-Stage Oncology Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Late-Stage Oncology Drug Sales by Country (kg), 2021–2026
Table 32. Europe Late-Stage Oncology Drug Sales by Country (kg), 2027–2032
Table 33. Europe Late-Stage Oncology Drug Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Late-Stage Oncology Drug Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Late-Stage Oncology Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Late-Stage Oncology Drug Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Late-Stage Oncology Drug Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Late-Stage Oncology Drug Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Late-Stage Oncology Drug Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Late-Stage Oncology Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Late-Stage Oncology Drug Sales by Country (kg), 2021–2026
Table 42. Latin America Late-Stage Oncology Drug Sales by Country (kg), 2027–2032
Table 43. Latin America Late-Stage Oncology Drug Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Late-Stage Oncology Drug Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Late-Stage Oncology Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Late-Stage Oncology Drug Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Late-Stage Oncology Drug Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Late-Stage Oncology Drug Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Late-Stage Oncology Drug Revenue by Country (US$ Million), 2027–2032
Table 50. Global Late-Stage Oncology Drug Sales (kg) by Type (2021–2026)
Table 51. Global Late-Stage Oncology Drug Sales (kg) by Type (2027–2032)
Table 52. Global Late-Stage Oncology Drug Sales Market Share by Type (2021–2026)
Table 53. Global Late-Stage Oncology Drug Sales Market Share by Type (2027–2032)
Table 54. Global Late-Stage Oncology Drug Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Late-Stage Oncology Drug Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Late-Stage Oncology Drug Revenue Market Share by Type (2021–2026)
Table 57. Global Late-Stage Oncology Drug Revenue Market Share by Type (2027–2032)
Table 58. Global Late-Stage Oncology Drug Price (US$/g) by Type (2021–2026)
Table 59. Global Late-Stage Oncology Drug Price (US$/g) by Type (2027–2032)
Table 60. Global Late-Stage Oncology Drug Sales (kg) by Application (2021–2026)
Table 61. Global Late-Stage Oncology Drug Sales (kg) by Application (2027–2032)
Table 62. Global Late-Stage Oncology Drug Sales Market Share by Application (2021–2026)
Table 63. Global Late-Stage Oncology Drug Sales Market Share by Application (2027–2032)
Table 64. Global Late-Stage Oncology Drug Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Late-Stage Oncology Drug Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Late-Stage Oncology Drug Revenue Market Share by Application (2021–2026)
Table 67. Global Late-Stage Oncology Drug Revenue Market Share by Application (2027–2032)
Table 68. Global Late-Stage Oncology Drug Price (US$/g) by Application (2021–2026)
Table 69. Global Late-Stage Oncology Drug Price (US$/g) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Roche Late-Stage Oncology Drug Product
Table 74. Roche Recent Developments/Updates
Table 75. Merck & Co Company Information
Table 76. Merck & Co Description and Business Overview
Table 77. Merck & Co Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Merck & Co Late-Stage Oncology Drug Product
Table 79. Merck & Co Recent Developments/Updates
Table 80. Bristol Myers Company Information
Table 81. Bristol Myers Description and Business Overview
Table 82. Bristol Myers Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Bristol Myers Late-Stage Oncology Drug Product
Table 84. Bristol Myers Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Pfizer Late-Stage Oncology Drug Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Novartis Late-Stage Oncology Drug Product
Table 94. Novartis Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. AstraZeneca Late-Stage Oncology Drug Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Johnson & Johnson Company Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. Johnson & Johnson Late-Stage Oncology Drug Product
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Eli Lilly and Company Company Information
Table 106. Eli Lilly and Company Description and Business Overview
Table 107. Eli Lilly and Company Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. Eli Lilly and Company Late-Stage Oncology Drug Product
Table 109. Eli Lilly and Company Recent Developments/Updates
Table 110. Sanofi Company Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. Sanofi Late-Stage Oncology Drug Product
Table 114. Sanofi Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. AbbVie Late-Stage Oncology Drug Product
Table 119. AbbVie Recent Developments/Updates
Table 120. GSK Company Information
Table 121. GSK Description and Business Overview
Table 122. GSK Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 123. GSK Late-Stage Oncology Drug Product
Table 124. GSK Recent Developments/Updates
Table 125. Amgen Company Information
Table 126. Amgen Description and Business Overview
Table 127. Amgen Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 128. Amgen Late-Stage Oncology Drug Product
Table 129. Amgen Recent Developments/Updates
Table 130. Genentech Company Information
Table 131. Genentech Description and Business Overview
Table 132. Genentech Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 133. Genentech Late-Stage Oncology Drug Product
Table 134. Genentech Recent Developments/Updates
Table 135. Daiichi Sankyo Group Company Information
Table 136. Daiichi Sankyo Group Description and Business Overview
Table 137. Daiichi Sankyo Group Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 138. Daiichi Sankyo Group Late-Stage Oncology Drug Product
Table 139. Daiichi Sankyo Group Recent Developments/Updates
Table 140. Aveo Oncology Company Information
Table 141. Aveo Oncology Description and Business Overview
Table 142. Aveo Oncology Late-Stage Oncology Drug Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 143. Aveo Oncology Late-Stage Oncology Drug Product
Table 144. Aveo Oncology Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Late-Stage Oncology Drug Distributors List
Table 148. Late-Stage Oncology Drug Customers List
Table 149. Late-Stage Oncology Drug Market Trends
Table 150. Late-Stage Oncology Drug Market Drivers
Table 151. Late-Stage Oncology Drug Market Challenges
Table 152. Late-Stage Oncology Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Late-Stage Oncology Drug
Figure 2. Global Late-Stage Oncology Drug Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Late-Stage Oncology Drug Market Share by Type: 2025 & 2032
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Hormonal Therapy Product Picture
Figure 8. Others Product Picture
Figure 9. Global Late-Stage Oncology Drug Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Late-Stage Oncology Drug Market Share by Application: 2025 & 2032
Figure 11. Blood Cancer
Figure 12. Breast Cancer
Figure 13. Gastrointestinal Cancer
Figure 14. Prostate Cancer
Figure 15. Respiratory or Lung Cancer
Figure 16. Other
Figure 17. Global Late-Stage Oncology Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Late-Stage Oncology Drug Market Size (US$ Million), 2021–2032
Figure 19. Global Late-Stage Oncology Drug Sales (kg), 2021–2032
Figure 20. Global Late-Stage Oncology Drug Average Price (US$/g), 2021–2032
Figure 21. Late-Stage Oncology Drug Report Years Considered
Figure 22. Late-Stage Oncology Drug Sales Share by Manufacturers in 2025
Figure 23. Global Late-Stage Oncology Drug Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Late-Stage Oncology Drug Players: Market Share by Revenue in Late-Stage Oncology Drug in 2025
Figure 25. Late-Stage Oncology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Late-Stage Oncology Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Late-Stage Oncology Drug Sales Market Share by Country (2021–2032)
Figure 28. North America Late-Stage Oncology Drug Revenue Market Share by Country (2021–2032)
Figure 29. United States Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Late-Stage Oncology Drug Sales Market Share by Country (2021–2032)
Figure 32. Europe Late-Stage Oncology Drug Revenue Market Share by Country (2021–2032)
Figure 33. Germany Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Late-Stage Oncology Drug Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Late-Stage Oncology Drug Revenue Market Share by Region (2021–2032)
Figure 40. China Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America Late-Stage Oncology Drug Sales Market Share by Country (2021–2032)
Figure 48. Latin America Late-Stage Oncology Drug Revenue Market Share by Country (2021–2032)
Figure 49. Mexico Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa Late-Stage Oncology Drug Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa Late-Stage Oncology Drug Revenue Market Share by Country (2021–2032)
Figure 55. Turkey Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE Late-Stage Oncology Drug Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of Late-Stage Oncology Drug by Type (2021–2032)
Figure 59. Global Revenue Market Share of Late-Stage Oncology Drug by Type (2021–2032)
Figure 60. Global Late-Stage Oncology Drug Price (US$/g) by Type (2021–2032)
Figure 61. Global Sales Market Share of Late-Stage Oncology Drug by Application (2021–2032)
Figure 62. Global Revenue Market Share of Late-Stage Oncology Drug by Application (2021–2032)
Figure 63. Global Late-Stage Oncology Drug Price (US$/g) by Application (2021–2032)
Figure 64. Late-Stage Oncology Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
